Evidence map›Paper›PMID 11000255›Full record

ArticleJournal of virology2000

Identification of Notch1 as a frequent target for provirus insertional mutagenesis in T-cell lymphomas induced by leukemogenic mutants of mouse mammary tumor virus.

S Yanagawa, J S Lee, K Kakimi, Y Matsuda, T Honjo, A Ishimoto

Abstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Leukemia-specific delivery of mutant NOTCH1 targeted therapy.The Journal of experimental medicine · 2018
    Article
  3. Article
  4. Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.Laboratory investigation; a journal of technical methods and pathology · 2015
    Article
  5. Article
  6. Article
  7. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

S YanagawaDepartment of Viral Oncology, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan. syanagaw@virus.kyoto-u.ac.jp
J S Lee
K Kakimi
Y Matsuda
T Honjo
A Ishimoto
Baruch S. Blumberg Institute · USKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contrast to wild-type mouse mammary tumor virus (MMTV), the MMTV mutants with specific deletions in the U3 region of their long terminal repeats cause T-cell lymphomas. In 30% of T-cell lymphomas arising in BALB/c mice infected with MLA-MMTV, a leukemogenic MMTV mutant, we have found that MMTV proviruses were integrated into a short region of the Notch1 genome, so that truncated Notch1 transcripts encoding the transmembrane and the cytoplasmic domains of Notch1 protein could be expressed. Thus, Notch1 is a major target of provirus insertional mutagenesis in these T-cell lymphomas.

Indexed as

Mutagenesis, InsertionalReceptors, Cell SurfaceTranscription FactorsAnimalsBase SequenceGene RearrangementLymphoma, T-CellMammary Tumor Virus, MouseMembrane ProteinsMiceMice, Inbred BALB CMolecular Sequence DataProvirusesReceptor, Notch1RNA, MessengerTerminal Repeat SequencesMembrane ProteinsNotch1 protein, mouseReceptor, Notch1Receptors, Cell SurfaceRNA, MessengerTranscription Factors

Identifiers

PMID11000255
PMCPMC112415
OpenAlexW2004815476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.